MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    Multiple system atrophy mimicked by mitochondrial disease.

    L. Diaz-Feliz, P. Garcia-Ruiz (Madrid, Spain)

    Objective: Characterized a case with A3243G mutation in mtDNA tRNALeu, a variant of mitochondrial disease; MELAS, which presents with atypical parkinsonism as Multiple system atrophy.…
  • 2022 International Congress

    Is there a role for safinamide in atypical parkinsonian syndromes?

    A. Silva, M. Rodrigues (Braga, Portugal)

    Objective: To search for possible benefits of safinamide in atypical parkinsonism. Background: Safinamide is a selective reversible monoamine oxidase-B inhibitor with both dopaminergic and glutamatergic…
  • 2022 International Congress

    Month 24 results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort

    M. Zafar, J. Soto, E. Baloga, L. Omberg, E. Macklin, P. Snyder, K. Amodeo, T. Meyers, S. Duquette, C. Stevens, K. Lizzaraga, E. Nnadika, A. Sarkar, C. Tarolli, J. Adams, C. Lungu, J. Gottesman, B. Valdovinos, E. Dorsey, L. Mangravite, T. Simuni, M. Schwarzchild, R. Schneider (Rochester, USA)

    Objective: To describe the change in characteristics of Parkinson’s disease (PD) clinical trial participants over 24 months following trial participation in a remote, longitudinal observational…
  • 2022 International Congress

    Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism

    E. Zinoviev, M. Ganapathy, M. Siddiqui (Winston-Salem, USA)

    Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…
  • 2022 International Congress

    Expanding the armamentarium of clinical use of apomorphine in movement disorders.

    S. Bansal, JR. Chai, M. Jog (London, Canada)

    Objective: To demonstrate the use of subcutaneous(SC) apomorphine injections in suspected untreated dopamine responsive conditions. Background: Apomorphine is a dopamine agonist historically used in dopamine…
  • 2022 International Congress

    Screening of REM Sleep Behavior Disorder and the relation with parkinsonism symptoms in the elderly in southern Brazil: a preliminary population-based study

    G. Pereira, N. Soares, E. Moriguchi, J. Senger, M. Sartori, N. Bruscato, C. Bertocchi, L. Netson, R. Almeida, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To describe the preliminary screening profile for suspected REM sleep behavior disorders (RBD) and association with parkinsonian symptoms in the elderly in a population-based…
  • 2022 International Congress

    Protective approach targeting NF-kB/ Nrf2 signaling and neuroinflammation using Apigenin in LPS induced Parkinsonism in experimental rats

    S. Singh (Moga, India)

    Objective: 1. Apigenin as a protective strategy to prevent neuroinflammation in PD.2. To find behavioral, neurochemical and histopathological changes in LPS induced PD. Background: Parkinson’s…
  • 2022 International Congress

    Prospective, Multicenter, International Registry of Deep Brain Stimulation for Essential Tremor

    G. Deuschl, R. Schuurman, G. Loret, N. Kovacs, M. Blázquez Estrada, F. Clement, J. Il Lee, L. Chen, R. Jain (Kiel, Germany)

    Objective: This is a new Essential Tremor (ET) patient registry for patients implanted with a multiple-source, constant-current DBS system capable of providing directionality for use…
  • 2022 International Congress

    Atypical parkinsonism presenting in late 60s in an individual with GCH1 mutation

    P. Barbosa, MG. Ghilardi, AC. Campos, F. Curado, P. Bauer, E. Fonoff (Sao Paulo, Brazil)

    Objective: To report a case of possible comorbid tau and Lewy pathology in an individual with a GCH1 mutation. Background: A 69-year-old man developed atypical parkinsonism…
  • 2022 International Congress

    Referral for movement disorder specialists within a central hospital

    AG. Velon, AJ. Marques, A. Costa, C. Borges, C. Azoia, R. Raimundo (Vila Real, Portugal)

    Objective: Characterization of in-hospital observation requests for movement disorders specialty. Background: The increasing prevalence of movement disorders may lead to high patient referral for movement…
  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley